949
Views
11
CrossRef citations to date
0
Altmetric
Poison Centre Research

The unknown known: non-cardiogenic pulmonary edema in amlodipine poisoning, a cohort study

, , , , &
Pages 1042-1049 | Received 13 Oct 2019, Accepted 22 Jan 2020, Published online: 02 Mar 2020

References

  • Swedish National Board of Health and Welfare [Internet]. Statistical database for medicinal products. [cited 2019 Jun 29]. Available from: https://sdb.socialstyrelsen.se/if_lak/val.aspx
  • Lindeman E, Baer Eriksson L, Thorsson M, et al. High dose insulin euglycemia therapy – an important addition to the treatment arsenal in severe toxic myocardial depression. Lakartidningen. 2017;114. pii: EPDS. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28994852
  • Grass, JN, Ahlner, J, Kugelberg FC, et al. The great molasses flood: volume overload and pulmonary symptoms after high dose insulin therapy in amlodipine poisoning. Clin Toxicol 2019;57(6):504–504 [Abstract 175].
  • Herrington DM, Insley BM, Weinmann GG. Nifedipine overdose. Am J Med. 1986;81(2):344–346.
  • Humbert VH, Jr, Munn NJ, Hawkins RF. Noncardiogenic pulmonary edema complicating massive diltiazem overdose. Chest. 1991;99(1):258–259.
  • Makani H, Bangalore S, Romero J, et al. Peripheral edema associated with calcium channel blockers: incidence and withdrawal rate–a meta-analysis of randomized trials. J Hypertens. 2011;29(7):1270–1280.
  • Gustafsson D. Microvascular mechanisms involved in calcium antagonist edema formation. J Cardiovasc Pharmacol. 1987;10(Suppl 1):S121–S131.
  • Tatara T. Context-sensitive fluid therapy in critical illness. J Intensive Care. 2016;4(1):20.
  • Bärtsch P, Maggiorini M, Ritter M, et al. Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med. 1991;325(18):1284–1289.
  • Woodmansey PA, O’Toole L, Channer KS, et al. Acute pulmonary vasodilatory properties of amlodipine in humans with pulmonary hypertension. Heart. 1996;75(2):171–173.
  • Brass BJ, Winchester-Penny S, Lipper BL. Massive verapamil overdose complicated by noncardiogenic pulmonary edema. Am J Emerg Med. 1996;14(5):459–461.
  • Sami Karti S, Ulusoy H, Yandi M, et al. Non-cardiogenic pulmonary oedema in the course of verapamil intoxication. Emerg Med J. 2002;19(5):458–459.
  • Saravu K, Balasubramanian R. Near-fatal amlodipine poisoning. J Assoc Phys India. 2004;52:156–157.
  • Vogt S, Mehlig A, Hunziker P, et al. Survival of severe amlodipine intoxication due to medical intensive care. Forensic Sci Int. 2006;161(2–3):216–220.
  • Ghosh S, Sircar M. Calcium channel blocker overdose: experience with amlodipine. Indian J Crit Care Med. 2008;12(4):190–193.
  • Selej M, Farber M. Noncardiogenic Pulmonary Edema in Amlodipine Overdose. Chest. 2011;140(4):130A.
  • Kute VB, Shah PR, Goplani KR, et al. Successful treatment of refractory hypotension, noncardiogenic pulmonary edema and acute kidney injury after an overdose of amlodipine. Indian J Crit Care Med. 2011;15(3):182–184.
  • Rizvi I, Ahmad A, Gupta A, et al. Life-threatening calcium channel blocker overdose and its management. BMJ Case Rep. 2012;2012. pii: bcr0120125643.
  • Hasson R, Mulcahy V, Tahir H. Amlodipine poisioning complicated with acute non-cardiogenic pulmonary oedema. BMJ Case Rep. 2011;2011. pii: bcr0720114467.
  • Upreti V, Ratheesh VR, Dhull P, Handa A. Shock due to amlodipine overdose. Indian J Crit Care Med. 2013;17(6):375–377.
  • Naha K, Suryanarayana J, Aziz RA, et al. Amlodipine poisoning revisited: Acidosis, acute kidney injury and acute respiratory distress syndrome. Indian J Crit Care Med. 2014;18(7):467–469.
  • Shetty K, Sherif L, Babu R, et al. Noninvasive ventilation in a patient with noncardiogenic pulmonary edema following amlodipine poisoning. J Anaesthesiol Clin Pharmacol. 2015;31(2):264–266.
  • Hedaiaty M, Eizadi-Mood N, Sabzghabaee AM. Noncardiogenic pulmonary edema after amlodipine overdose without refractory hypotension and bradycardia. Case Rep Emerg Med. 2015;2015:546012.
  • Stanek EJ, Nelson CE, DeNofrio D. Amlodipine overdose. Ann Pharmacother. 1997;31(7–8):853–856.
  • St-Onge M, Brent J. Calcium-channel blocking agents. In: Brent J, Burkhart K, Dargan PI, Hatten B, Mégarbane B, Palmer RB , editors. Critical care toxicology: diagnosis and management of the critically poisoned patient. 2nd ed. Cham: Springer; 2017. p. 787–805.
  • Jang DH. Calcium channel blockers. In: Nelson LS, Howland MA, Lewin NA, Smith SW, Goldfrank LR, Hoffman RS, editors. Goldfrank's Toxicologic Emergencies. 11th ed. New York: McGraw-Hill; 2018. p. 945–952.
  • Linnet K, Lang LM, Johansen SS. Postmortem femoral blood concentrations of amlodipine. J Anal Toxicol. 2011;35(4):227–231.
  • Dekkers OM, Egger M, Altman DG, et al. Distinguishing case series from cohort studies. Ann Intern Med. 2012;156(1_Part_1):37–40.
  • Roman M, Ström L, Tell H, et al. Liquid chromatography/time-of-flight mass spectrometry analysis of postmortem blood samples for targeted toxicological screening. Anal Bioanal Chem. 2013;405(12):4107–4125.
  • St-Onge M, Anseeuw K, Cantrell FL, et al. Experts consensus recommendations for the management of calcium channel blocker poisoning in adults. Crit Care Med. 2017;45(3):e306–e315.
  • Laskey D, Vadlapatla R, Hart K. Stability of high-dose insulin in normal saline bags for treatment of calcium channel blocker and beta blocker overdose. Clin Toxicol. 2016;54(9):829–832.
  • Schimmel J, Monte AA. Risk of fluid overload from failure to concentrate high-dose insulin as an intravenous antidote. Ann Pharmacother. 2019;53(3):325–325.
  • Matthay MA, Zemans RL, Zimmerman GA, et al. Acute respiratory distress syndrome. Nat Rev Dis Primers. 2019;5(1):18.
  • Nordmark Grass J, Ahlner J, Kugelberg FC, et al. A case of massive metoprolol and amlodipine overdose with blood concentrations and survival following extracorporeal corporeal membrane oxygenation (ECMO). Clin Toxicol. 2019;57(1):66–68.
  • Kao R, Landry Y, Chick G, et al. Bilateral blindness secondary to optic nerve ischemia from severe amlodipine overdose: a case report. J Med Case Rep. 2017;11(1):211.
  • Levine M, Boyer EW, Pozner CN, et al. Assessment of hyperglycemia after calcium channel blocker overdoses involving diltiazem or verapamil. Crit Care Med. 2007;35(9):2071–2075.
  • Kline JA, Raymond RM, Schroeder JD, et al. The diabetogenic effects of acute verapamil poisoning. Toxicol Appl Pharmacol. 1997;145(2):357–362.
  • Bonadonna RC, Groop L, Kraemer N, et al. Obesity and insulin resistance in humans: a dose-response study. Metabolism. 1990;39(5):452–459.
  • Haughey R, Vernick W, Gutsche J, et al. Use of veno-venous extracorporeal membrane oxygenation to treat severe combined calcium channel blocker and angiotensin converting enzyme inhibitor overdose. Perfusion. 2019;34(2):167–169.
  • Cole JB, Arens AM, Laes JR, et al. High dose insulin for beta-blocker and calcium channel-blocker poisoning. Am J Emerg Med. 2018;36(10):1817–1824.
  • Skoog CA, Engebretsen KM. Are vasopressors useful in toxin-induced cardiogenic shock?. Clin Toxicol. 2017;55(4):285–304.
  • Katzung KG, Leroy JM, Boley SP, et al. A randomized controlled study comparing high-dose insulin to vasopressors or combination therapy in a porcine model of refractory propranolol-induced cardiogenic shock. Clin Toxicol. 2019;57(11):1073–1079.
  • Breu AC. Why is a cow? Curiosity, tweetorials, and the return to why. N Engl J Med. 2019;381(12):1097–1098.
  • Breu A. How do calcium channel blockers (e.g. amlodipine) cause edema? [Internet]. Twitter. 31 may 2019. [cited 2019 Oct 9]; Available from: https://twitter.com/tony_breu/status/1134521056167944192

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.